首页> 外文期刊>Molecular human reproduction. >Generation of immortalized human endometrial stromal cell lines with different endometriosis risk genotypes
【24h】

Generation of immortalized human endometrial stromal cell lines with different endometriosis risk genotypes

机译:用不同的子宫内膜异位症风险基因型产生永生化人的子宫内膜间质细胞系

获取原文
获取原文并翻译 | 示例
       

摘要

Endometriotic lesions are composed in part of endometrial-like stromal cells, however, there is a shortage of immortalized human endometrial stromal cultures available for research. As genetic factors play a role in endometriosis risk, it is important that genotype is also incorporated into analysis of pathological mechanisms. Human telomerase reverse transcriptase (hTERT) immortalization (using Lenti-hTERT-green fluorescent protein virus) took place following genotype selection; 13 patients homozygous for either the risk or non-risk 'other' allele for one or more important endometriosis risk single nucleotide polymorphism on chromosome 1 p36.12 (rs3820282, rs563 18008, rs55938609, rs 12037376, rs7521902 or rs 12061255). Short tandem repeat DN A profiling validated that donor tissue matched that of the immortalized cell lines and confirmed that cultures were genetically novel. Expression of morphological markers (vimentin and cytokeratin) and key genes of interest (telomerase, estrogen and progesterone receptors and LINC00339) were examined and functional assays for cell proliferation, steroid hormone and inflammatory responses were performed for 7,13 cultures. All endometrial stromal cell lines maintained their fibroblast-like morphology (vimentin-positive) and homozygous endometriosis-risk genotype following introduction of hTERT. Furthermore, the new stromal cultures demonstrated positive and diverse responses to hormones (proliferation and decidualisation changes) and inflammation (dose-dependent response), while maintaining hormone receptor expression. In conclusion, we successfully developed a range of human endometrial stromal cell lines that carry important endometriosis-risk alleles. The wider implications of this approach go beyond advancing endometriosis research; these cell lines will be valuable tools for multiple endometrial pathologies offering a level of genetic and phenotypic diversity not previously available.
机译:子宫内膜静脉病变部分组成部分子宫内膜样基质细胞,然而,可用于研究的永生化的人子宫内膜基质培养物的短缺。随着遗传因素在子宫内膜异位症风险中发挥作用,重要的是,基因型也被纳入病理机制的分析中。在基因型选择之后发生了人端粒酶逆转录酶(HTERT)永生化(使用熊酸盐 - 绿色荧光蛋白病毒); 13名患者纯合的风险或非风险“其他”等位基因,用于一种或多种重要的子宫内膜症风险单核苷酸在染色体上的单核苷酸多态性1 p36.12(RS3820282,RS563 18008,RS55938609,RS7521902或RS7521902或RS为12061255)。简短的串联重复DN验证的剖面验证了供体组织与永生化细胞系的匹配并证实培养物是遗传新的。检查了形态标志物(皮瓣和细胞角蛋白)的表达和感兴趣的关键基因(端粒酶,雌激素和孕酮受体和LINC00339),并对细胞增殖,类固醇激素和炎症反应进行功能测定,对7,13种培养物进行。所有子宫内膜基质细胞系保持其成纤维细胞样形态(Vimentin阳性)和纯合的子宫内膜异位症 - 风险基因型,后引入HTETT。此外,新的基质培养物证明了对激素(增殖和解除症)和炎症(剂量依赖性反应)的阳性和不同的反应,同时保持激素受体表达。总之,我们成功地开发了一系列人的子宫内膜体间细胞系,携带重要的子宫内膜异位症 - 风险等位基因。这种方法的更广泛的影响超出了促进子宫内膜异位症研究;这些细胞系将是用于多个子宫内膜病理的有价值的工具,提供以前没有以前可用的遗传和表型多样性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号